Medicine and Dentistry
Somatomedin C
100%
Ganglioneuroblastoma
33%
Receptor
22%
Phosphorylation
22%
Stimulation
22%
Neuroblastoma Cell
22%
Mitogen-Activated Protein Kinase
22%
2 (2 Amino 3 Methoxyphenyl)chromone
22%
Messenger RNA
11%
RNA
11%
Protein
11%
Cell Type
11%
Signal Transduction
11%
Pathogenesis
11%
Combination Therapy
11%
Neuroblastoma Cell Line
11%
Kinase Signaling
11%
Mitogen Activated Protein Kinase 3
11%
Neutralizing Antibody
11%
Somatomedin C Receptor
11%
Cell Cycle Progression
11%
Oncoprotein
11%
Growth
11%
Mitogen Activated Protein Kinase 1
11%
MAPK Signaling
11%
Oncogene Myc
11%
Cells
11%
Survival
11%
Differentiation
11%
Mitogen-Activated Protein Kinase
11%
Prognosis
11%
Pediatrics
11%
Neuroscience
N-Myc
100%
Insulin-Like Growth Factor 1
100%
Neuroblastoma
66%
Eicosanoid Receptor
22%
Phosphorylation
22%
Cell Line
11%
RNA
11%
Cell Signaling
11%
Cell Cycle Progression
11%
Mitogen Activated Protein Kinase 3
11%
Neutralizing Antibody
11%
Extracellular Signal-Regulated Kinases
11%
Mitogen-Activated Protein Kinase
11%
Oncoprotein
11%
Mitogen Activated Protein Kinase 1
11%
Insulin-Like Growth Factor 1 Receptor
11%
S Cell
11%
MAPK Signaling
11%
Protein
11%
Pediatrics
11%
Oncogene Myc
11%
Biochemistry, Genetics and Molecular Biology
N-Myc
100%
Phosphorylation
22%
Mitogen-Activated Protein Kinase
22%
Signal Transduction
11%
Insulin-Like Growth Factor 1 Receptor
11%
Experimental Model
11%
Cell Cycle Progression
11%
Neutralizing Antibody
11%
MAPK Signaling
11%
Growth
11%
S Cell
11%
Reduction (Chemistry)
11%
Survival
11%
Time
11%
Messenger RNA
11%
Pediatrics
11%
Oncogene Myc
11%